Veeva Systems Inc.
Veeva Systems Inc. VEEV Peers
See (VEEV) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VEEV | $285.20 | +1.49% | 46.6B | 60.59 | $4.71 | N/A |
| GEHC | $76.49 | +3.13% | 35B | 16.07 | $4.76 | +0.17% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.17% |
| DOCS | $59.38 | -1.44% | 11.2B | 53.52 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.41 | +0.34% | 8.4B | 71.10 | $1.37 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSG | $20.15 | +2.23% | 3.5B | 74.63 | $0.27 | N/A |
| BTSGU | $70.45 | -0.01% | 3.5B | N/A | N/A | N/A |
| ONEM | $16.47 | +0.00% | 3.4B | -7.77 | -$2.12 | N/A |
Stock Comparison
VEEV vs GEHC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, GEHC has a market cap of 35B. Regarding current trading prices, VEEV is priced at $285.20, while GEHC trades at $76.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas GEHC's P/E ratio is 16.07. In terms of profitability, VEEV's ROE is +0.14%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, VEEV is less volatile compared to GEHC. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs GEHCV Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, VEEV is priced at $285.20, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas GEHCV's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, VEEV is less volatile compared to GEHCV. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs DOCS Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, DOCS has a market cap of 11.2B. Regarding current trading prices, VEEV is priced at $285.20, while DOCS trades at $59.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas DOCS's P/E ratio is 53.52. In terms of profitability, VEEV's ROE is +0.14%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, VEEV is less volatile compared to DOCS. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SGFY Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, VEEV is priced at $285.20, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SGFY's P/E ratio is 70.91. In terms of profitability, VEEV's ROE is +0.14%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, VEEV is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs HQY Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, HQY has a market cap of 8.4B. Regarding current trading prices, VEEV is priced at $285.20, while HQY trades at $97.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas HQY's P/E ratio is 71.10. In terms of profitability, VEEV's ROE is +0.14%, compared to HQY's ROE of +0.06%. Regarding short-term risk, VEEV is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs RCM Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, VEEV is priced at $285.20, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas RCM's P/E ratio is -102.21. In terms of profitability, VEEV's ROE is +0.14%, compared to RCM's ROE of -0.02%. Regarding short-term risk, VEEV is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs BTSG Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BTSG has a market cap of 3.5B. Regarding current trading prices, VEEV is priced at $285.20, while BTSG trades at $20.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BTSG's P/E ratio is 74.63. In terms of profitability, VEEV's ROE is +0.14%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, VEEV is less volatile compared to BTSG. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs BTSGU Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BTSGU has a market cap of 3.5B. Regarding current trading prices, VEEV is priced at $285.20, while BTSGU trades at $70.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BTSGU's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, VEEV is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs ONEM Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, VEEV is priced at $285.20, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ONEM's P/E ratio is -7.77. In terms of profitability, VEEV's ROE is +0.14%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, VEEV is less volatile compared to ONEM. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs PRVA Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PRVA has a market cap of 2.4B. Regarding current trading prices, VEEV is priced at $285.20, while PRVA trades at $20.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PRVA's P/E ratio is 167.33. In terms of profitability, VEEV's ROE is +0.14%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, VEEV is less volatile compared to PRVA. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs WGS Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, WGS has a market cap of 2.3B. Regarding current trading prices, VEEV is priced at $285.20, while WGS trades at $80.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas WGS's P/E ratio is -58.20. In terms of profitability, VEEV's ROE is +0.14%, compared to WGS's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to WGS. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs PGNY Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, VEEV is priced at $285.20, while PGNY trades at $22.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PGNY's P/E ratio is 40.32. In terms of profitability, VEEV's ROE is +0.14%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, VEEV is less volatile compared to PGNY. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs GDRX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, GDRX has a market cap of 1.8B. Regarding current trading prices, VEEV is priced at $285.20, while GDRX trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas GDRX's P/E ratio is 70.29. In terms of profitability, VEEV's ROE is +0.14%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, VEEV is less volatile compared to GDRX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs PINC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PINC has a market cap of 1.7B. Regarding current trading prices, VEEV is priced at $285.20, while PINC trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PINC's P/E ratio is 20.71. In terms of profitability, VEEV's ROE is +0.14%, compared to PINC's ROE of +0.03%. Regarding short-term risk, VEEV is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs CERT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CERT has a market cap of 1.7B. Regarding current trading prices, VEEV is priced at $285.20, while CERT trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CERT's P/E ratio is -531.00. In terms of profitability, VEEV's ROE is +0.14%, compared to CERT's ROE of -0.00%. Regarding short-term risk, VEEV is less volatile compared to CERT. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SDGR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SDGR has a market cap of 1.7B. Regarding current trading prices, VEEV is priced at $285.20, while SDGR trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SDGR's P/E ratio is -8.66. In terms of profitability, VEEV's ROE is +0.14%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, VEEV is less volatile compared to SDGR. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs TXG Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, TXG has a market cap of 1.6B. Regarding current trading prices, VEEV is priced at $285.20, while TXG trades at $12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas TXG's P/E ratio is -10.15. In terms of profitability, VEEV's ROE is +0.14%, compared to TXG's ROE of -0.22%. Regarding short-term risk, VEEV is less volatile compared to TXG. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs NXGN Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, VEEV is priced at $285.20, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas NXGN's P/E ratio is -266.00. In terms of profitability, VEEV's ROE is +0.14%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, VEEV is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs PHR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PHR has a market cap of 1.6B. Regarding current trading prices, VEEV is priced at $285.20, while PHR trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PHR's P/E ratio is -36.22. In terms of profitability, VEEV's ROE is +0.14%, compared to PHR's ROE of -0.16%. Regarding short-term risk, VEEV is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs TDOC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, TDOC has a market cap of 1.5B. Regarding current trading prices, VEEV is priced at $285.20, while TDOC trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas TDOC's P/E ratio is -1.42. In terms of profitability, VEEV's ROE is +0.14%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, VEEV is less volatile compared to TDOC. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs AGTI Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, VEEV is priced at $285.20, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas AGTI's P/E ratio is -71.79. In terms of profitability, VEEV's ROE is +0.14%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, VEEV is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs OMCL Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, OMCL has a market cap of 1.3B. Regarding current trading prices, VEEV is priced at $285.20, while OMCL trades at $28.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas OMCL's P/E ratio is 61.43. In terms of profitability, VEEV's ROE is +0.14%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, VEEV is less volatile compared to OMCL. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs EVH Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, EVH has a market cap of 1.1B. Regarding current trading prices, VEEV is priced at $285.20, while EVH trades at $9.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas EVH's P/E ratio is -7.95. In terms of profitability, VEEV's ROE is +0.14%, compared to EVH's ROE of -0.11%. Regarding short-term risk, VEEV is less volatile compared to EVH. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs HSTM Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, HSTM has a market cap of 812.3M. Regarding current trading prices, VEEV is priced at $285.20, while HSTM trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas HSTM's P/E ratio is 42.24. In terms of profitability, VEEV's ROE is +0.14%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, VEEV is less volatile compared to HSTM. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CTEV Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CTEV has a market cap of 701.8M. Regarding current trading prices, VEEV is priced at $285.20, while CTEV trades at $42.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CTEV's P/E ratio is -0.59. In terms of profitability, VEEV's ROE is +0.14%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, VEEV is less volatile compared to CTEV. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SY Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SY has a market cap of 694.4M. Regarding current trading prices, VEEV is priced at $285.20, while SY trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SY's P/E ratio is -6.58. In terms of profitability, VEEV's ROE is +0.14%, compared to SY's ROE of -0.28%. Regarding short-term risk, VEEV is less volatile compared to SY. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs MPLN-WT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, VEEV is priced at $285.20, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, VEEV is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ACCD Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, VEEV is priced at $285.20, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ACCD's P/E ratio is -3.08. In terms of profitability, VEEV's ROE is +0.14%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, VEEV is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs NUTX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, NUTX has a market cap of 555.6M. Regarding current trading prices, VEEV is priced at $285.20, while NUTX trades at $100.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas NUTX's P/E ratio is 8.10. In terms of profitability, VEEV's ROE is +0.14%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, VEEV is less volatile compared to NUTX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SHCR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, VEEV is priced at $285.20, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SHCR's P/E ratio is -3.76. In terms of profitability, VEEV's ROE is +0.14%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, VEEV is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs DH Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, DH has a market cap of 440.1M. Regarding current trading prices, VEEV is priced at $285.20, while DH trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas DH's P/E ratio is -0.93. In terms of profitability, VEEV's ROE is +0.14%, compared to DH's ROE of -1.07%. Regarding short-term risk, VEEV is less volatile compared to DH. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SLGCW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, VEEV is priced at $285.20, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, VEEV's ROE is +0.14%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, VEEV is less volatile compared to SLGCW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SLGC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, VEEV is priced at $285.20, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SLGC's P/E ratio is -3.04. In terms of profitability, VEEV's ROE is +0.14%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, VEEV is less volatile compared to SLGC. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs MPLN Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, VEEV is priced at $285.20, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MPLN's P/E ratio is -0.23. In terms of profitability, VEEV's ROE is +0.14%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, VEEV is less volatile compared to MPLN. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SPOK Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SPOK has a market cap of 361.5M. Regarding current trading prices, VEEV is priced at $285.20, while SPOK trades at $17.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SPOK's P/E ratio is 22.82. In terms of profitability, VEEV's ROE is +0.14%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, VEEV is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs TBRG Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, TBRG has a market cap of 336.1M. Regarding current trading prices, VEEV is priced at $285.20, while TBRG trades at $22.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas TBRG's P/E ratio is -18.04. In terms of profitability, VEEV's ROE is +0.14%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, VEEV is less volatile compared to TBRG. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs NRC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, NRC has a market cap of 322.6M. Regarding current trading prices, VEEV is priced at $285.20, while NRC trades at $14.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas NRC's P/E ratio is 13.88. In terms of profitability, VEEV's ROE is +0.14%, compared to NRC's ROE of +0.71%. Regarding short-term risk, VEEV is less volatile compared to NRC. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs TRHC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, VEEV is priced at $285.20, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas TRHC's P/E ratio is -4.27. In terms of profitability, VEEV's ROE is +0.14%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, VEEV is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs HCAT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, HCAT has a market cap of 274.2M. Regarding current trading prices, VEEV is priced at $285.20, while HCAT trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas HCAT's P/E ratio is -3.43. In terms of profitability, VEEV's ROE is +0.14%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, VEEV is less volatile compared to HCAT. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SLP Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SLP has a market cap of 262.2M. Regarding current trading prices, VEEV is priced at $285.20, while SLP trades at $13.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SLP's P/E ratio is -4.14. In terms of profitability, VEEV's ROE is +0.14%, compared to SLP's ROE of -0.37%. Regarding short-term risk, VEEV is less volatile compared to SLP. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SMFR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, VEEV is priced at $285.20, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SMFR's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to SMFR. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs OPRX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, OPRX has a market cap of 246M. Regarding current trading prices, VEEV is priced at $285.20, while OPRX trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas OPRX's P/E ratio is -15.83. In terms of profitability, VEEV's ROE is +0.14%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, VEEV is less volatile compared to OPRX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SOPH Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SOPH has a market cap of 229.2M. Regarding current trading prices, VEEV is priced at $285.20, while SOPH trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SOPH's P/E ratio is -3.43. In terms of profitability, VEEV's ROE is +0.14%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, VEEV is less volatile compared to SOPH. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CPSI Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, VEEV is priced at $285.20, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CPSI's P/E ratio is -183.80. In terms of profitability, VEEV's ROE is +0.14%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, VEEV is less volatile compared to CPSI. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs AMWL Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, AMWL has a market cap of 130.9M. Regarding current trading prices, VEEV is priced at $285.20, while AMWL trades at $8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas AMWL's P/E ratio is -0.82. In terms of profitability, VEEV's ROE is +0.14%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, VEEV is less volatile compared to AMWL. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs AUGX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, VEEV is priced at $285.20, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas AUGX's P/E ratio is -4.99. In terms of profitability, VEEV's ROE is +0.14%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, VEEV is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs EUDA Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, EUDA has a market cap of 112.2M. Regarding current trading prices, VEEV is priced at $285.20, while EUDA trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas EUDA's P/E ratio is -5.59. In terms of profitability, VEEV's ROE is +0.14%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, VEEV is less volatile compared to EUDA. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CCLD Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CCLD has a market cap of 102M. Regarding current trading prices, VEEV is priced at $285.20, while CCLD trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CCLD's P/E ratio is -10.95. In terms of profitability, VEEV's ROE is +0.14%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, VEEV is less volatile compared to CCLD. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CCLDO Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CCLDO has a market cap of 101.1M. Regarding current trading prices, VEEV is priced at $285.20, while CCLDO trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CCLDO's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, VEEV is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs FORA Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, FORA has a market cap of 60.2M. Regarding current trading prices, VEEV is priced at $285.20, while FORA trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas FORA's P/E ratio is -16.08. In terms of profitability, VEEV's ROE is +0.14%, compared to FORA's ROE of -0.13%. Regarding short-term risk, VEEV is less volatile compared to FORA. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CCLDP Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, VEEV is priced at $285.20, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CCLDP's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, VEEV is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs BEAT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BEAT has a market cap of 43.2M. Regarding current trading prices, VEEV is priced at $285.20, while BEAT trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BEAT's P/E ratio is -1.73. In terms of profitability, VEEV's ROE is +0.14%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, VEEV is less volatile compared to BEAT. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs BEATW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BEATW has a market cap of 43M. Regarding current trading prices, VEEV is priced at $285.20, while BEATW trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BEATW's P/E ratio is -0.57. In terms of profitability, VEEV's ROE is +0.14%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, VEEV is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SNCE Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, VEEV is priced at $285.20, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SNCE's P/E ratio is -0.27. In terms of profitability, VEEV's ROE is +0.14%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, VEEV is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs AKLI Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, VEEV is priced at $285.20, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas AKLI's P/E ratio is -0.71. In terms of profitability, VEEV's ROE is +0.14%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, VEEV is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs SHLT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, VEEV is priced at $285.20, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SHLT's P/E ratio is -3.87. In terms of profitability, VEEV's ROE is +0.14%, compared to SHLT's ROE of -0.07%. Regarding short-term risk, VEEV is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs SHCRW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, VEEV is priced at $285.20, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.14%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, VEEV is less volatile compared to SHCRW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SCNX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SCNX has a market cap of 28.9M. Regarding current trading prices, VEEV is priced at $285.20, while SCNX trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SCNX's P/E ratio is 3.33. In terms of profitability, VEEV's ROE is +0.14%, compared to SCNX's ROE of -0.24%. Regarding short-term risk, VEEV is less volatile compared to SCNX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ONMD Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ONMD has a market cap of 25M. Regarding current trading prices, VEEV is priced at $285.20, while ONMD trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ONMD's P/E ratio is -1.59. In terms of profitability, VEEV's ROE is +0.14%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, VEEV is less volatile compared to ONMD. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs STRM Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, STRM has a market cap of 23.1M. Regarding current trading prices, VEEV is priced at $285.20, while STRM trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas STRM's P/E ratio is -2.39. In terms of profitability, VEEV's ROE is +0.14%, compared to STRM's ROE of -0.68%. Regarding short-term risk, VEEV is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs RNLX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, VEEV is priced at $285.20, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas RNLX's P/E ratio is -0.33. In terms of profitability, VEEV's ROE is +0.14%, compared to RNLX's ROE of +1.94%. Regarding short-term risk, VEEV is less volatile compared to RNLX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs LIFW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, VEEV is priced at $285.20, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas LIFW's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.14%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, VEEV is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs VSEE Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, VSEE has a market cap of 22.1M. Regarding current trading prices, VEEV is priced at $285.20, while VSEE trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas VSEE's P/E ratio is -14.10. In terms of profitability, VEEV's ROE is +0.14%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, VEEV is less volatile compared to VSEE. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs VSEEW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, VSEEW has a market cap of 21.1M. Regarding current trading prices, VEEV is priced at $285.20, while VSEEW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas VSEEW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, VEEV is less volatile compared to VSEEW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs MGRX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MGRX has a market cap of 17.4M. Regarding current trading prices, VEEV is priced at $285.20, while MGRX trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MGRX's P/E ratio is -0.35. In terms of profitability, VEEV's ROE is +0.14%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, VEEV is less volatile compared to MGRX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs BBLN Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, VEEV is priced at $285.20, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BBLN's P/E ratio is -0.04. In terms of profitability, VEEV's ROE is +0.14%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, VEEV is less volatile compared to BBLN. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs BFRGW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BFRGW has a market cap of 13.9M. Regarding current trading prices, VEEV is priced at $285.20, while BFRGW trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BFRGW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to BFRGW's ROE of -1.63%. Regarding short-term risk, VEEV is less volatile compared to BFRGW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs BFRG Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, BFRG has a market cap of 13.8M. Regarding current trading prices, VEEV is priced at $285.20, while BFRG trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas BFRG's P/E ratio is -1.86. In terms of profitability, VEEV's ROE is +0.14%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, VEEV is less volatile compared to BFRG. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs INOV Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, INOV has a market cap of 12.9M. Regarding current trading prices, VEEV is priced at $285.20, while INOV trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas INOV's P/E ratio is 16.50. In terms of profitability, VEEV's ROE is +0.14%, compared to INOV's ROE of +0.03%. Regarding short-term risk, VEEV is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs MSPR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MSPR has a market cap of 9.8M. Regarding current trading prices, VEEV is priced at $285.20, while MSPR trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MSPR's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, VEEV is less volatile compared to MSPR. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ETAO Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, VEEV is priced at $285.20, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ETAO's P/E ratio is -0.01. In terms of profitability, VEEV's ROE is +0.14%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, VEEV is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs HCTI Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, HCTI has a market cap of 7.8M. Regarding current trading prices, VEEV is priced at $285.20, while HCTI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas HCTI's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.14%, compared to HCTI's ROE of -23.25%. Regarding short-term risk, VEEV is less volatile compared to HCTI. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs HLTH Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, VEEV is priced at $285.20, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas HLTH's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.14%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, VEEV is less volatile compared to HLTH. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ZCMD Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ZCMD has a market cap of 5.8M. Regarding current trading prices, VEEV is priced at $285.20, while ZCMD trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ZCMD's P/E ratio is -9.33. In terms of profitability, VEEV's ROE is +0.14%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, VEEV is less volatile compared to ZCMD. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs UPH Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, VEEV is priced at $285.20, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas UPH's P/E ratio is -0.07. In terms of profitability, VEEV's ROE is +0.14%, compared to UPH's ROE of -1.05%. Regarding short-term risk, VEEV is less volatile compared to UPH. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ACON Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ACON has a market cap of 4.4M. Regarding current trading prices, VEEV is priced at $285.20, while ACON trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ACON's P/E ratio is -0.65. In terms of profitability, VEEV's ROE is +0.14%, compared to ACON's ROE of -1.27%. Regarding short-term risk, VEEV is less volatile compared to ACON. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs PEAR Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, VEEV is priced at $285.20, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PEAR's P/E ratio is -0.08. In terms of profitability, VEEV's ROE is +0.14%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, VEEV is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs PEARW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, VEEV is priced at $285.20, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas PEARW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.14%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, VEEV is less volatile compared to PEARW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs OTRK Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, OTRK has a market cap of 4M. Regarding current trading prices, VEEV is priced at $285.20, while OTRK trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas OTRK's P/E ratio is -0.03. In terms of profitability, VEEV's ROE is +0.14%, compared to OTRK's ROE of -2.70%. Regarding short-term risk, VEEV is less volatile compared to OTRK. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs EUDAW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, EUDAW has a market cap of 3.7M. Regarding current trading prices, VEEV is priced at $285.20, while EUDAW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas EUDAW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, VEEV is less volatile compared to EUDAW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs FOXO Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, FOXO has a market cap of 3.3M. Regarding current trading prices, VEEV is priced at $285.20, while FOXO trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas FOXO's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.14%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, VEEV is less volatile compared to FOXO. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs CMAX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, VEEV is priced at $285.20, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CMAX's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.14%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, VEEV is less volatile compared to CMAX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs WORX Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, WORX has a market cap of 1.5M. Regarding current trading prices, VEEV is priced at $285.20, while WORX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas WORX's P/E ratio is -0.47. In terms of profitability, VEEV's ROE is +0.14%, compared to WORX's ROE of -0.32%. Regarding short-term risk, VEEV is less volatile compared to WORX. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs LIFWZ Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, VEEV is priced at $285.20, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, VEEV is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs WGSWW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, WGSWW has a market cap of 1.2M. Regarding current trading prices, VEEV is priced at $285.20, while WGSWW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas WGSWW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs OTRKP Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, OTRKP has a market cap of 1.1M. Regarding current trading prices, VEEV is priced at $285.20, while OTRKP trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, VEEV's ROE is +0.14%, compared to OTRKP's ROE of -2.70%. Regarding short-term risk, VEEV is less volatile compared to OTRKP. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs ICCT Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ICCT has a market cap of 585.3K. Regarding current trading prices, VEEV is priced at $285.20, while ICCT trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ICCT's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to ICCT's ROE of +20.01%. Regarding short-term risk, VEEV is less volatile compared to ICCT. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs KERN Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, VEEV is priced at $285.20, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas KERN's P/E ratio is -0.01. In terms of profitability, VEEV's ROE is +0.14%, compared to KERN's ROE of -2.22%. Regarding short-term risk, VEEV is less volatile compared to KERN. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs KERNW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, VEEV is priced at $285.20, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas KERNW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.14%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, VEEV is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs MSPRZ Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MSPRZ has a market cap of 86.1K. Regarding current trading prices, VEEV is priced at $285.20, while MSPRZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, VEEV is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs LIFWW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, VEEV is priced at $285.20, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas LIFWW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, VEEV is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs CMAXW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, VEEV is priced at $285.20, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CMAXW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, VEEV is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs ACONW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, VEEV is priced at $285.20, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas ACONW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, VEEV is less volatile compared to ACONW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs MSPRW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MSPRW has a market cap of 9.3K. Regarding current trading prices, VEEV is priced at $285.20, while MSPRW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MSPRW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, VEEV is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs UTRS Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, UTRS has a market cap of 888. Regarding current trading prices, VEEV is priced at $285.20, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas UTRS's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, VEEV is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs CNVY Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, VEEV is priced at $285.20, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CNVY's P/E ratio is -71.50. In terms of profitability, VEEV's ROE is +0.14%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, VEEV is more volatile compared to CNVY. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs CHNG Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, VEEV is priced at $285.20, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas CHNG's P/E ratio is -152.72. In terms of profitability, VEEV's ROE is +0.14%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, VEEV is more volatile compared to CHNG. This indicates potentially higher risk in terms of short-term price fluctuations for VEEV.
VEEV vs MTBC Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, VEEV is priced at $285.20, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas MTBC's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to MTBC's ROE of +0.21%. Regarding short-term risk, VEEV is less volatile compared to MTBC. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.
VEEV vs SMFRW Comparison
VEEV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 46.6B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, VEEV is priced at $285.20, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 60.59, whereas SMFRW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.14%, compared to SMFRW's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to SMFRW. This indicates potentially lower risk in terms of short-term price fluctuations for VEEV.